Inventor · disambiguated record
Erol K. Bayburt
Also filed as: BAYBURT EROL K
24 granted patents·6 pending applications·152 citations·filing 2001–2013
95Inventor score
Top patents by PatentIndex Score
30 records- 0195US7015233B2Fused compounds that inhibit vanilloid subtype 1 (VR1) receptorABBOTT LAB·Filed 2003·Granted Mar 21, 2006·39 cites·15 claims
- 0293US8026256B2Fused compounds that inhibit vanilloid subtype 1 (VR1) receptorABBOTT LAB·Filed 2005·Granted Sep 27, 2011·11 cites·6 claims
- 0388US8487116B2Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorGOMTSYAN ARTHUR R·Filed 2011·Granted Jul 16, 2013·5 cites·14 claims
- 0488US8084616B2TRPV1 antagonistsGOMTSYAN ARTHUR R·Filed 2008·Granted Dec 27, 2011·12 cites·13 claims
- 0587US8071762B2Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorGOMTSYAN ARTHUR R·Filed 2008·Granted Dec 6, 2011·5 cites·5 claims
- 0685US7998993B2TRPV1 antagonistsABBOTT LAB·Filed 2008·Granted Aug 16, 2011·8 cites·15 claims
- 0785US6933311B2Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorABBOTT LAB·Filed 2003·Granted Aug 23, 2005·24 cites·23 claims
- 0882US7074805B2Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorABBOTT LAB·Filed 2003·Granted Jul 11, 2006·10 cites·69 claims
- 0980US7335678B2Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1(VR1) receptorABBOTT LAB·Filed 2004·Granted Feb 26, 2008·8 cites·12 claims
- 1078US7375126B2Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorABBOTT LAB·Filed 2004·Granted May 20, 2008·9 cites·8 claims
- 1176US8232309B2Prodrugs of compounds that inhibit TRPV1 receptorGOMTSYAN ARTHUR R·Filed 2006·Granted Jul 31, 2012·2 cites·22 claims
- 1276US6831193B2Trisubstituted-N-[(1S)-1,2,3,4-Tetrahydro-1-naphthalenyl]benzamides which inhibit P2X3 and P2X2/3 containing receptorsABBOTT LAB·Filed 2002·Granted Dec 14, 2004·8 cites·68 claims
- 1373US8604053B2TRPV1 antagonistsGOMTSYAN ARTHUR R·Filed 2009·Granted Dec 10, 2013·2 cites·32 claims
- 1469US8772499B2TRPV3 modulatorsABBVIE INC·Filed 2012·Granted Jul 8, 2014·1 cites·45 claims
- 1569US8772500B2TRPV3 modulatorsABBVIE INC·Filed 2012·Granted Jul 8, 2014·1 cites·33 claims
- 1669US6693136B1Fluorenes and anthracenes that inhibit P2X3 and P2X2/3 containing receptorsABBOTT LAB·Filed 2002·Granted Feb 17, 2004·7 cites·25 claims
- 1765US2008153809A1Novel amides useful for treating painABBOTT LAB·Filed 2008·Application pending·0 cites
- 1864US8247413B2Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorLEE CHIH-HUNG·Filed 2008·Granted Aug 21, 2012·0 cites·10 claims
- 1961US8030504B2Antagonists of the TRPV1 receptor and uses thereofABBOTT LAB·Filed 2007·Granted Oct 4, 2011·0 cites·9 claims
- 2055US2013165479A1Antagonists of the trpv1 receptor and uses thereofABBVIE INC·Filed 2012·Application pending·0 cites
- 2153US8350083B2Antagonists of the TRPV1 receptor and uses thereofABBVIE INC·Filed 2011·Granted Jan 8, 2013·0 cites·16 claims
- 2252US7812019B2Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereofABBOTT LAB·Filed 2005·Granted Oct 12, 2010·0 cites·21 claims
- 2351US8609692B2TRPV1 antagonistsGOMTSYAN ARTHUR R·Filed 2009·Granted Dec 17, 2013·0 cites·24 claims
- 2448US8338603B2TRPV1 antagonistsGOMTSYAN ARTHUR R·Filed 2011·Granted Dec 25, 2012·0 cites·6 claims
- 2548US2003158188A1Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorFiled 2002·Application pending·0 cites
- 2648US2012277190A1Prodrugs of compounds that inhibit trpv1 receptorGOMTSYAN ARTHUR R·Filed 2012·Application pending·0 cites
- 2744US2005113576A1Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorFiled 2004·Application pending·0 cites
- 2842US9156788B2TRPV3 modulatorsABBVIE INC·Filed 2013·Granted Oct 13, 2015·0 cites·11 claims
- 2940US8440691B2Tetrahydroquinolinyl compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereofGOMTSYAN ARTHUR·Filed 2010·Granted May 14, 2013·0 cites·18 claims
- 3037US2002173665A1Trisubstituted-N-[(1S)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit P2X3 and P2X2/3 containing receptorsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Erol K. Bayburt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →